Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling.
作者信息
Sgodda Malte, Cantz Tobias
机构信息
Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany.
出版信息
Mol Ther. 2013 Jan;21(1):5-7. doi: 10.1038/mt.2012.273.
Abstract
摘要
相似文献
1
Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling.
Mol Ther. 2013 Jan;21(1):5-7. doi: 10.1038/mt.2012.273.
2
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.
Mol Ther. 2013 Jan;21(1):228-39. doi: 10.1038/mt.2012.245. Epub 2012 Nov 27.
3
Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
J Biol Chem. 2017 Aug 25;292(34):14066-14079. doi: 10.1074/jbc.M117.784280. Epub 2017 Mar 30.
4
Diabetes forum: Extreme makeover of pancreatic alpha-cells.
Nature. 2010 Apr 22;464(7292):1132-3. doi: 10.1038/4641132a.
5
Generation of pluripotent stem cells from patients with type 1 diabetes.
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15768-73. doi: 10.1073/pnas.0906894106. Epub 2009 Aug 31.
6
iPS cells in type 1 diabetes research and treatment.
Clin Pharmacol Ther. 2011 May;89(5):750-3. doi: 10.1038/clpt.2011.1. Epub 2011 Mar 23.
7
[Immunocytochemical morphometry in type I and type II diabetes mellitus].
Dtsch Med Wochenschr. 1983 Feb 4;108(5):188-9. doi: 10.1055/s-2008-1069526.
8
Generation of insulin-producing cells from human adipose-derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol.
J Cell Physiol. 2018 May;233(5):4327-4337. doi: 10.1002/jcp.26266. Epub 2017 Dec 26.
9
Generation of pancreatic islet cells from human embryonic stem cells.
Sci China C Life Sci. 2009 Jul;52(7):615-21. doi: 10.1007/s11427-009-0095-3. Epub 2009 Jul 30.
10
In vitro (re)programming of human bone marrow stromal cells toward insulin-producing phenotypes.
Pediatr Diabetes. 2009 Sep;10(6):413-9. doi: 10.1111/j.1399-5448.2009.00502.x. Epub 2009 Jul 13.
引用本文的文献
1
Assessing the effects of methylphenidate in proliferation and Wnt activity of neuronal stem cells from attention deficit/hyperactivity disorder patients.
J Neural Transm (Vienna). 2025 Jul 28. doi: 10.1007/s00702-025-02988-y.
2
Graft-derived neurons and bystander effects are maintained for six months after human iPSC-derived NESC transplantation in mice's cerebella.
Sci Rep. 2024 Feb 8;14(1):3236. doi: 10.1038/s41598-024-53542-x.
3
Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
Cells. 2020 Sep 10;9(9):2065. doi: 10.3390/cells9092065.
4
Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease.
Stem Cells Transl Med. 2020 Aug;9(8):867-881. doi: 10.1002/sctm.19-0433. Epub 2020 Apr 9.
5
Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.
Cell Stem Cell. 2016 Sep 1;19(3):311-25. doi: 10.1016/j.stem.2016.07.006. Epub 2016 Aug 18.
6
Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells.
PLoS One. 2015 Aug 17;10(8):e0134995. doi: 10.1371/journal.pone.0134995. eCollection 2015.
7
Human iPSC derived disease model of MERTK-associated retinitis pigmentosa.
Sci Rep. 2015 Aug 11;5:12910. doi: 10.1038/srep12910.
本文引用的文献
1
Targeting DNA With Fingers and TALENs.
Mol Ther Nucleic Acids. 2012 Jan 24;1(1):e3. doi: 10.1038/mtna.2011.5.
2
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.
Mol Ther. 2013 Jan;21(1):228-39. doi: 10.1038/mt.2012.245. Epub 2012 Nov 27.
3
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
Nature. 2012 Dec 20;492(7429):438-42. doi: 10.1038/nature11629. Epub 2012 Nov 18.
4
In vitro modeling of paraxial mesodermal progenitors derived from induced pluripotent stem cells.
PLoS One. 2012;7(10):e47078. doi: 10.1371/journal.pone.0047078. Epub 2012 Oct 24.
5
In vivo genome editing using a high-efficiency TALEN system.
Nature. 2012 Nov 1;491(7422):114-8. doi: 10.1038/nature11537. Epub 2012 Sep 23.
6
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.
Cell Stem Cell. 2012 May 4;10(5):570-82. doi: 10.1016/j.stem.2012.03.002. Epub 2012 Apr 26.
7
Self-renewing endodermal progenitor lines generated from human pluripotent stem cells.
Cell Stem Cell. 2012 Apr 6;10(4):371-84. doi: 10.1016/j.stem.2012.02.024.
8
Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells.
Cell Stem Cell. 2011 Dec 2;9(6):588-98. doi: 10.1016/j.stem.2011.11.003.
9
Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072. Epub 2011 May 4.
10
Somatic coding mutations in human induced pluripotent stem cells.
Nature. 2011 Mar 3;471(7336):63-7. doi: 10.1038/nature09805.
Zotero 插件